| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -7.8e-05 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -2.4e-05 | 1 |